{"mainPropery":{"diseaseId":4107,"diseaseName":"Optic pathway glioma","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/4107/optic-pathway-glioma","synonyms":[],"synonyms-with-source":[],"identifiers":[{"identifierType":"ORPHANET","identifierId":"2086"}]},"diseaseCategories":[{"diseaseTypeId":8,"diseaseTypeName":"Endocrine Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"},{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[],"resource descriptions":[{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Optic+pathway+glioma%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Optic pathway glioma. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2086' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:2086' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":12697,"relatedDiseaseName":"Tumor of cranial and spinal nerves","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":9337,"phenoTypeName":"Neurofibromas","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10124,"phenoTypeName":"Optic atrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9162,"phenoTypeName":"Visual loss","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10089,"phenoTypeName":"Blindness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5154,"phenoTypeName":"Developmental regression","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13593,"phenoTypeName":"Fatigable weakness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4082,"phenoTypeName":"Growth delay","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11409,"phenoTypeName":"Headache","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9825,"phenoTypeName":"Hydrocephalus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13408,"phenoTypeName":"Nausea","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9185,"phenoTypeName":"Ophthalmoplegia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9348,"phenoTypeName":"Papilledema","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6031,"phenoTypeName":"Precocious puberty","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9804,"phenoTypeName":"Proptosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10498,"phenoTypeName":"Strabismus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11411,"phenoTypeName":"Vertigo","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9372,"phenoTypeName":"Visual field defect","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13400,"phenoTypeName":"Vomiting","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[],"EncodedName":"Optic_pathway_glioma"}